Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.
Yamazaki K, Shimizu M, Okuno M, Matsushima-Nishiwaki R, Kanemura N, Araki H, Tsurumi H, Kojima S, Weinstein IB, Moriwaki H. Yamazaki K, et al. Among authors: kanemura n. Gut. 2007 Nov;56(11):1557-63. doi: 10.1136/gut.2007.129858. Epub 2007 Jun 29. Gut. 2007. PMID: 17604322 Free PMC article.
A prospective study of P-IMVP-16/CBDCA: a novel salvage chemotherapy for patients with aggressive non-Hodgkin's lymphoma who had previously received CHOP therapy as first-line chemotherapy.
Sawada M, Tsurumi H, Yamada T, Hara T, Fukuno K, Goto H, Shimizu M, Kasahara S, Yoshikawa T, Kanemura N, Oyama M, Takami T, Moriwaki H. Sawada M, et al. Among authors: kanemura n. Eur J Haematol. 2002 Jun;68(6):354-61. doi: 10.1034/j.1600-0609.2002.01654.x. Eur J Haematol. 2002. PMID: 12225393 Free article. Clinical Trial.
Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
Tsurumi H, Yamada T, Sawada M, Kasahara S, Kanemura N, Kojima Y, Fukuno K, Hara T, Saio M, Takahashi T, Oyama M, Ozawa K, Takami T, Moriwaki H. Tsurumi H, et al. Among authors: kanemura n. J Cancer Res Clin Oncol. 2004 Feb;130(2):107-13. doi: 10.1007/s00432-003-0508-9. Epub 2003 Nov 27. J Cancer Res Clin Oncol. 2004. PMID: 14648210 Clinical Trial.
CD20-negative pyothorax-associated B cell lymphoma.
Fukuno K, Tsurumi H, Kanemura N, Nishio M, Tanabashi S, Okamoto K, Moriwaki H. Fukuno K, et al. Among authors: kanemura n. Acta Haematol. 2005;113(2):144-5. doi: 10.1159/000083453. Acta Haematol. 2005. PMID: 15802894
Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
Kojima Y, Tsurumi H, Goto N, Shimizu M, Kasahara S, Yamada T, Kanemura N, Hara T, Sawada M, Saio M, Yamada T, Takahashi T, Tomita E, Takami T, Moriwaki H. Kojima Y, et al. Among authors: kanemura n. Eur J Haematol. 2006 Jun;76(6):465-72. doi: 10.1111/j.1600-0609.2006.00631.x. Epub 2006 Feb 23. Eur J Haematol. 2006. PMID: 16494623 Free article.
159 results